Mitofusins Mfn1 and Mfn2 Are Required in the Β-Cell to Preserve Mitochondrial

Total Page:16

File Type:pdf, Size:1020Kb

Mitofusins Mfn1 and Mfn2 Are Required in the Β-Cell to Preserve Mitochondrial bioRxiv preprint doi: https://doi.org/10.1101/2020.04.22.055384; this version posted January 12, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Mitofusins Mfn1 and Mfn2 are required in the β-cell to preserve mitochondrial architecture and insulin secretion Eleni Georgiadou1, Charanya Muralidharan2, Michelle Martinez2, Pauline Chabosseau1, Alejandra Tomas1, Fiona Yong Su Wern3, Theodoros Stylianides4, Asger Wretlind5, Cristina Legido-Quigley5,6, Nour Alsabeeh7, Céline Cruciani-Guglielmacci8, Christophe Magnan8, Mark Ibberson9, Isabelle Leclerc1, Yusuf Ali3, Amelia K. Linnemann2, Tristan A. Rodriguez10 and Guy A. Rutter1,3*. 1Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, W12 0NN, UK 2Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, 46202, USA 3Lee Kong Chian School of Medicine, Nanyang Technological University, 637553, Singapore 4Loughborough University, Centre of Innovative and Collaborative Construction Engineering, Leicestershire, LE11 3TU, UK 5Systems Medicin, Steno Diabetes Center Copenhagen, 2820, Denmark 6 Institute of Pharmaceutical Science, Kings College London, London, SE1 9NH, UK 7 Kuwait University, Department of Physiology, Health Sciences Center, 13110, Kuwait 8Université de Paris, BFA, UMR 8251, CNRS, Regulation of Glycemia by Central Nervous System, Paris, 75205, France 9Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, CH-1015,Switzerland 10National Heart and Lung Institute, Imperial Centre for Translational and Experimental Medicine, Imperial College London, London, W12 0NN, UK *Address correspondence to Professor Guy A. Rutter, [email protected], +44 20 759 43340 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.04.22.055384; this version posted January 12, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Summary Mitochondrial glucose metabolism is essential for the initiation of insulin release from pancreatic β-cells. Fusion of mitochondria is supported by mitofusin 1 (MFN1) and mitofusin 2 (MFN2). Whether this process is important for glucose sensing by β-cells is unclear. Here, we generated mice with β-cell-selective, adult-restricted deletion of Mfn1 and Mfn2 (Mfn1/2-KO), and explored the impact on insulin secretion and glucose homeostasis. Mfn1/2-KO mice displayed higher glycaemia and a >five-fold decrease in plasma insulin post-intraperitoneal glucose injection. Mitochondrial length, glucose-induced hyperpolarization, ATP synthesis and Ca2+ accumulation were significantly reduced in Mfn1/2-KO mouse islets. Ca2+ dynamics and mitochondrial membrane potential changes were also suppressed in vivo. Defective glucose- stimulated insulin secretion in islets isolated from Mfn1/2-KO mice was nevertheless normalised by the addition of GLP-1 receptor agonists. Mitochondrial fusion and fission cycles are thus essential in the β-cell to maintain normal mitochondrial bioenergetics and glucose sensing both in vitro and in vivo. Keywords: Type 2 diabetes, pancreatic β-cell, mitochondrial dysfunction, mitofusins, glucose stimulated insulin secretion, Ca2+ dynamics, incretins, GLP-1, GIP, Exendin- 4. 2 bioRxiv preprint doi: https://doi.org/10.1101/2020.04.22.055384; this version posted January 12, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Introduction Mitochondria are often referred to as the powerhouses or, more recently, as the “chief executive organelles” (CEO) of the cell, generating most of the energy required to sustain normal function (Anderson, Jackson et al. 2019). Mitochondria are responsible for NAD and NADH production via the Krebs cycle, oxidative phosphorylation, ATP synthesis, fatty acid oxidation and gluconeogenesis, and mitochondrial DNA (mtDNA) distribution. They also contribute to the regulation of apoptosis and their own turnover via mitophagy (Chandhok, Lazarou et al. 2018). Mitochondrial oxidative metabolism plays a pivotal role in the response of pancreatic β-cells to stimulation by glucose and other nutrients (Panten and Ishida 1974, Maechler and Wollheim 2001, Rutter, Pullen et al. 2015). Thus, as the blood glucose levels increase in the blood, enhanced glycolytic flux and oxidative metabolism in β- cells lead to an increase in ATP synthesis, initiating a cascade of events which involve + the closure of ATP-sensitive K (KATP) channels (Rorsman and Ashcroft 2018), plasma membrane depolarisation and the influx of Ca2+ via voltage-gated Ca2+ channels (VDCC). The latter mechanism, along with other, less well defined amplifying signals (Henquin 2000), drive the biphasic release of insulin (Rutter, Pullen et al. 2015). The possibility that changes in mitochondrial function in these cells may contribute to declining insulin secretion and to type 2 diabetes (T2D) has been the subject of extensive investigation (Supale, Li et al. 2012). Reduced glucose-stimulated insulin secretion (GSIS) in β-cells, alongside altered mitochondrial function, dynamics and morphology, were observed in diabetic models (Del Guerra, Lupi et al. 2005, Mulder and Ling 2009, Rutter GA, Georgiadou E et al. 2020). 3 bioRxiv preprint doi: https://doi.org/10.1101/2020.04.22.055384; this version posted January 12, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Besides synthesizing ATP, mitochondria are also one of the main producers of rative oxygen species (ROS) in the cell, inducing oxidative stress and tissue damage (Szendroedi, Phielix et al. 2012). Mitochondrial dysfunction in type 2 diabetic or obese patients suffering from hyperglycaemia was shown to be directly linked with lowered ATP levels and mitochondrial content as well as the development of insulin resistance (Rovira-Llopis, Banuls et al. 2017). Additionally, mitochondrial DNA (mtDNA) variations in human populations are associated with increased or decreased risk of T2D (van den Ouweland, Maechler et al. 1999), while in animal models, alterations in β-cell mtDNA lead to reduced insulin secretion, hyperglycaemia and β-cell death (Haythorne, Rohm et al. 2019). The multifaceted roles of mitochondria in the cell are associated with an equally variable morphology. Under normal physiological conditions, these organelles repetitively undergo fusion and fission cycles which are essential for their quality control and adaptation to energetic demands (Wada and Nakatsuka 2016). Thus, highly inter-connected mitochondrial networks allow communication and interchange of contents between mitochondrial compartments, as well as with other organelles such as the ER (Rutter and Rizzuto 2000). These networks exist interchangeably with more fragmented structures, displaying more “classical” mitochondrial morphology, with the balance between the two influenced by external stimuli and metabolic demands (Westermann 2012). In many cell types, including insulinoma-derived INS1 cells, a pro-fused state is often observed during starvation where energy production is required for cytoprotection and resistance to apoptosis. The opposite pertains when cells are exposed to nutrient overload in obesity or T2D (Liesa and Shirihai 2013) which can stimulate mitochondrial fission and uncoupled respiration (Liesa and 4 bioRxiv preprint doi: https://doi.org/10.1101/2020.04.22.055384; this version posted January 12, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Shirihai 2013), but is critical for the elimination of damaged mitochondria by mitophagy (Wai and Langer 2016). Over the past two decades, considerable light has been shed upon the means through which mitochondrial dynamics are controlled at the molecular level. The mitofusins MFN1 and MFN2, homologues of the D. melanogaster fuzzy onions (fzo) and mitofusin (dmfn) gene products (Hwa, Hiller et al. 2002), are key mediators of outer mitochondrial membrane (OMM) fusion. Whilst optic atrophy protein 1 (OPA1) controls inner mitochondrial membrane (IMM) fusion, dynamin related protein 1 (DRP1) is responsible for mitochondrial fission (Yisang Yoon 2011). Other regulators include FIS1, mitochondrial fission factor (MFF) and MiD49/51 (Serasinghe and Chipuk 2017). In pancreatic β-cells, defects in mitochondrial structure and the accumulation of damaged or depolarised organelles are associated with the development of diabetes in patients and animal models (Wada and Nakatsuka 2016). Changes in mitochondrial fusion and fission dynamics are observed in the pancreatic β-cell in animal models of diabetes (Higa, Zhou et al. 1999, Supale, Li et al. 2012, Gao, Li et al. 2014), and patients with T2D and obesity exhibit smaller
Recommended publications
  • Amyloid Β-Peptide Increases Mitochondria-Endoplasmic
    cells Article Amyloid β-Peptide Increases Mitochondria-Endoplasmic Reticulum Contact Altering Mitochondrial Function and Autophagosome Formation in Alzheimer’s Disease-Related Models Nuno Santos Leal 1,*, Giacomo Dentoni 1 , Bernadette Schreiner 1 , Luana Naia 1, Antonio Piras 1, Caroline Graff 1, Antonio Cattaneo 2, Giovanni Meli 2 , Maho Hamasaki 3, Per Nilsson 1 and Maria Ankarcrona 1,* 1 Division of Neurogeriatrics, Department of Neurobiology, Care Science and Society, Karolinska Institutet, BioClinicum J9:20, Visionsgatan 4, 171 64 Solna, Sweden; [email protected] (G.D.); [email protected] (B.S.); [email protected] (L.N.); [email protected] (A.P.); caroline.graff@ki.se (C.G.); [email protected] (P.N.) 2 European Brain Research Institute (EBRI), Viale Regina Elena 295, 00161 Roma, Italy; [email protected] (A.C.); [email protected] (G.M.) 3 Department of Genetics, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan; [email protected] * Correspondence: [email protected] (N.S.L.); [email protected] (M.A.); Tel.: +44-122-333-4390 (N.S.L.); +46-852-483-577 (M.A.) Received: 23 October 2020; Accepted: 25 November 2020; Published: 28 November 2020 Abstract: Recent findings have shown that the connectivity and crosstalk between mitochondria and the endoplasmic reticulum (ER) at mitochondria–ER contact sites (MERCS) are altered in Alzheimer’s disease (AD) and in AD-related models. MERCS have been related to the initial steps of autophagosome formation as well as regulation of mitochondrial function. Here, the interplay between MERCS, mitochondria ultrastructure and function and autophagy were evaluated in different AD animal models with increased levels of Aβ as well as in primary neurons derived from these animals.
    [Show full text]
  • The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease
    International Journal of Molecular Sciences Review The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease Chunling Huang * , Ji Bian , Qinghua Cao, Xin-Ming Chen and Carol A. Pollock * Kolling Institute, Sydney Medical School, Royal North Shore Hospital, University of Sydney, St. Leonards, NSW 2065, Australia; [email protected] (J.B.); [email protected] (Q.C.); [email protected] (X.-M.C.) * Correspondence: [email protected] (C.H.); [email protected] (C.A.P.); Tel.: +61-2-9926-4784 (C.H.); +61-2-9926-4652 (C.A.P.) Abstract: Mitochondria are critical organelles that play a key role in cellular metabolism, survival, and homeostasis. Mitochondrial dysfunction has been implicated in the pathogenesis of diabetic kidney disease. The function of mitochondria is critically regulated by several mitochondrial protein kinases, including the phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1). The focus of PINK1 research has been centered on neuronal diseases. Recent studies have revealed a close link between PINK1 and many other diseases including kidney diseases. This review will provide a concise summary of PINK1 and its regulation of mitochondrial function in health and disease. The physiological role of PINK1 in the major cells involved in diabetic kidney disease including proximal tubular cells and podocytes will also be summarized. Collectively, these studies suggested that targeting PINK1 may offer a promising alternative for the treatment of diabetic kidney disease. Keywords: PINK1; diabetic kidney disease; mitochondria; mitochondria quality control; mitophagy Citation: Huang, C.; Bian, J.; Cao, Q.; 1. Introduction Chen, X.-M.; Pollock, C.A.
    [Show full text]
  • 2328.Full.Pdf
    Altered interplay between endoplasmic reticulum and mitochondria in Charcot–Marie–Tooth type 2A neuropathy Nathalie Bernard-Marissala,b,1, Gerben van Hamerenc, Manisha Junejad,e, Christophe Pellegrinof, Lauri Louhivuorig, Luca Bartesaghih,i, Cylia Rochata, Omar El Mansoura, Jean-Jacques Médardh,i, Marie Croisierj, Catherine Maclachlanj, Olivier Poirotk, Per Uhléng, Vincent Timmermand,e, Nicolas Tricaudc, Bernard L. Schneidera,1,2, and Roman Chrasth,i,1,2 aBrain Mind Institute, École Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland; bMarseille Medical Genetics, INSERM, Aix-Marseille Univ, 13385 Marseille, France; cINSERM U1051, Institut des Neurosciences de Montpellier, Université de Montpellier, 34295 Montpellier, France; dPeripheral Neuropathy Research Group, Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium; eInstitute Born Bunge, 2610 Antwerp, Belgium; fInstitut de Neurobiologie de la Méditerranée, INSERM, Aix-Marseille Univ, 13009 Marseille, France; gDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, 17177 Stockholm, Sweden; hDepartment of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden; iDepartment of Clinical Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden; jCentre of Interdisciplinary Electron Microscopy, École Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland; and kDepartment of Medical Genetics, University of Lausanne, 1005 Lausanne, Switzerland Edited by Stephen T. Warren, Emory University School of Medicine, Atlanta, GA, and approved December 14, 2018 (received for review June 26, 2018) Mutations in the MFN2 gene encoding Mitofusin 2 lead to the axons (8). However, the long-term progression of the disease and development of Charcot–Marie–Tooth type 2A (CMT2A), a domi- the mechanisms underlying motor and/or sensory dysfunction nant axonal form of peripheral neuropathy. Mitofusin 2 is local- have not been fully characterized in this model.
    [Show full text]
  • Mitochondrial Dynamic Abnormalities in Alzheimer's Disease Sirui Jiang Case Western Reserve University
    MITOCHONDRIAL DYNAMIC ABNORMALITIES IN ALZHEIMER’S DISEASE by SIRUI JIANG Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Dissertation Advisor: Dr. Xiongwei Zhu Department of Pathology CASE WESTERN RESERVE UNIVERSITY January 2019 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of SIRUI JIANG Candidate for the degree of Doctor of Philosophy* Dr. Shu Chen (Committee Chair) Dr. Xiongwei Zhu Dr. Xinglong Wang Dr. George Dubyak Dr. Charles Hoppel August 15, 2018 *We also certify that written approval has been obtained for any proprietary material contained therein Table of Contents Table of Contents 1 List of Figures 3 Acknowledgements 5 List of Abbreviations 7 Abstract 10 Chapter 1. Introduction 12 Introduction to Alzheimer’s Disease 13 General Information 13 Pathology 14 Pathogenesis 15 Introduction to Mitochondrial Dynamics 20 Mitochondrial Function and Neuronal Health 20 Mitochondrial Dynamics 21 Mitochondrial Dynamics and Mitochondrial Function 23 Mitochondrial Dynamics and Mitochondrial Transport 24 Mitochondrial Deficits in AD 26 Mitochondrial Dysfunction in AD 26 Aβ and Mitochondrial Dysfunction 27 Mitochondrial Dynamic Abnormalities in AD: Recent Advances 28 Conclusion 34 1 Chapter 2. Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex 36 Abstract 37 Background 39 Methods 43 Results 47 Discussion 54 Figures 60 Chapter 3. DLP1 Cleavage by Calpain in Alzheimer’s Disease 71 Abstract 72 Background 73 Methods 77 Results 80 Discussion 85 Figures 89 Chapter 4. Summary, Discussion and Future Directions 96 References 108 2 List of Figures Figure 2.1 Cre-mediated ablation of Mfn2 expression in the hippocampus and cortex of Mfn2 cKO mice 60 Figure 2.2 Quantification of DLP1 and OPA1 in cKO mice 61 Figure 2.3 Mfn2 ablation caused mitochondrial fragmentation and ultrastructural damage in the hippocampus in vivo as evidenced by electron microscopic analysis.
    [Show full text]
  • Viral Infection Modulates Mitochondrial Function
    International Journal of Molecular Sciences Review Viral Infection Modulates Mitochondrial Function Xiaowen Li 1,2,3, Keke Wu 1,2,3, Sen Zeng 1,2,3, Feifan Zhao 1,2,3, Jindai Fan 1,2,3, Zhaoyao Li 1,2,3, Lin Yi 1,2,3, Hongxing Ding 1,2,3, Mingqiu Zhao 1,2,3, Shuangqi Fan 1,2,3,* and Jinding Chen 1,2,3,* 1 College of Veterinary Medicine, South China Agricultural University, No. 483 Wushan Road, Tianhe District, Guangzhou 510642, China; [email protected] (X.L.); [email protected] (K.W.); [email protected] (S.Z.); [email protected] (F.Z.); [email protected] (J.F.); [email protected] (Z.L.); [email protected] (L.Y.); [email protected] (H.D.); [email protected] (M.Z.) 2 Guangdong Laboratory for Lingnan Modern Agriculture, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China 3 Key Laboratory of Zoonosis Prevention and Control of Guangdong Province, Guangzhou 510642, China * Correspondence: [email protected] (S.F.); [email protected] (J.C.); Tel.: +86-20-8528-8017 (S.F.); +86-20-8528-8017 (J.C.) Abstract: Mitochondria are important organelles involved in metabolism and programmed cell death in eukaryotic cells. In addition, mitochondria are also closely related to the innate immunity of host cells against viruses. The abnormality of mitochondrial morphology and function might lead to a variety of diseases. A large number of studies have found that a variety of viral infec- tions could change mitochondrial dynamics, mediate mitochondria-induced cell death, and alter the mitochondrial metabolic status and cellular innate immune response to maintain intracellular survival.
    [Show full text]
  • MFN2 Gene Mitofusin 2
    MFN2 gene mitofusin 2 Normal Function The MFN2 gene provides instructions for making a protein called mitofusin 2. This protein helps determine the shape and structure (morphology) of mitochondria, the energy-producing centers within cells. Mitofusin 2 is made in many types of cells and tissues, including muscles, the spinal cord, and the nerves that connect the brain and spinal cord to muscles and to sensory cells that detect sensations such as touch, pain, heat, and sound (peripheral nerves). Within cells, mitofusin 2 is found in the outer membrane that surrounds mitochondria. Mitochondria are dynamic structures that undergo changes in morphology through processes called fission (splitting into smaller pieces) and fusion (combining pieces). These changes in morphology are necessary for mitochondria to function properly. Mitofusin 2 helps to regulate the morphology of mitochondria by controlling the fusion process. Health Conditions Related to Genetic Changes Charcot-Marie-Tooth disease Researchers have identified more than 100 MFN2 gene mutations that cause a form of Charcot-Marie-Tooth disease known as type 2A. Charcot-Marie-Tooth disease damages the peripheral nerves, which can result in loss of sensation and wasting ( atrophy) of muscles in the feet, legs, and hands. Almost all of the MFN2 gene mutations that cause Charcot-Marie-Tooth disease change single protein building blocks (amino acids) in mitofusin 2. These changes alter a critical region in mitofusin 2, and the protein cannot function properly. A few mutations create a premature stop signal in the instructions for making mitofusin 2. As a result, no protein is produced, or an abnormally small protein is made.
    [Show full text]
  • Subjects with Early-Onset Type 2 Diabetes Show Defective Activation of the Skeletal Muscle PGC-1␣/Mitofusin-2 Regulatory Pathway in Response to Physical Activity
    Pathophysiology/Complications ORIGINAL ARTICLE Subjects With Early-Onset Type 2 Diabetes Show Defective Activation of the Skeletal Muscle PGC-1␣/Mitofusin-2 Regulatory Pathway in Response to Physical Activity 4 MARÍA ISABEL HERNANDEZ´ -ALVAREZ, FRANCIS FINUCANE, MD tive treatments to improve insulin sensi- 1,2,3 1,2,3 MSC MARC LIESA, PHD tivity. We have been studying the effects 4 5 HOOD THABIT, MD CHIARA CHIELLINI, PHD of a variety of exercise and dietary regi- 4 1,2,3 NICOLE BURNS, MSC DEBORAH NAON, MSC mens in these very insulin-resistant pa- 4 1,2,3 SYED SHAH, MD ANTONIO ZORZANO, PHD 4 4 tients. We recently demonstrated that a IMAD BREMA, MD OHN OLAN MD 4 J J. N , 3-month, four times weekly, aerobic ex- MENSUD HATUNIC, MD ercise intervention in subjects with early- onset type 2 diabetes failed to improve OBJECTIVE — Type 2 diabetes is associated with insulin resistance and skeletal muscle VO2max and had no significant effect on mitochondrial dysfunction. We have found that subjects with early-onset type 2 diabetes show whole-body or hepatic insulin sensitivity incapacity to increase VO2max in response to chronic exercise. This suggests a defect in muscle (3). Equally obese nondiabetic control mitochondrial response to exercise. Here, we have explored the nature of the mechanisms subjects had a 20% increase in VO2max involved. following the same regime. This sug- gested the possibility that, in these dia- RESEARCH DESIGN AND METHODS — Muscle biopsies were collected from young betic patients, chronic exercise training type 2 diabetic subjects and obese control subjects before and after acute or chronic exercise protocols, and the expression of genes and/or proteins relevant to mitochondrial function was failed to activate a mitochondrial oxida- measured.
    [Show full text]
  • Direct Small Molecule Activation of Mitofusins 4 5 Emmanouil Zacharioudakis1, Nikolaos Biris1, Thomas P
    bioRxiv preprint doi: https://doi.org/10.1101/301713; this version posted April 17, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 2 3 Direct Small Molecule Activation of Mitofusins 4 5 Emmanouil Zacharioudakis1, Nikolaos Biris1, Thomas P. Garner1, Yun Chen2, Ryan, Pekson2, 6 Rimpy Dhingra3, Gaetano Santulli4, Lorrie A. Kirshenbaum3, Richard N. Kitsis5*, Evripidis 7 Gavathiotis6* 8 9 1Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461 USA 10 2Department of Medicine and Wilf Family Cardiovascular Research Institute, Albert Einstein 11 College of Medicine, Bronx, NY, 10461 USA 12 3Department of Physiology and Pathophysiology and Department of Pharmacology and 13 Therapeutics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of 14 Manitoba, Winnipeg, Manitoba Canada and Institute of Cardiovascular Sciences, St. Boniface 15 Research Centre, Winnipeg, Manitoba, R2H2A6 Canada 16 4Department of Medicine, Wilf Family Cardiovascular Research Institute, and Einstein-Mount 17 Sinai Diabetes Research Center, Albert Einstein College of Medicine, Bronx, NY, 10461 USA 18 5Department of Medicine, Department of Cell Biology, Wilf Family Cardiovascular Research 19 Institute, Albert Einstein Cancer Center, and Einstein-Mount Sinai Diabetes Research Center, 20 Albert Einstein College of Medicine, Bronx, NY 10461 USA 21 6Department of Biochemistry, Department of Medicine, Wilf Family Cardiovascular Research 22 Institute, and Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, NY 23 10461 USA 24 25 *To whom correspondence should be addressed: 26 Evripidis Gavathiotis, Ph.D. 27 Albert Einstein College of Medicine 28 Forchheimer G46 29 1300 Morris Park Avenue 30 Bronx, NY 10461 USA 31 Tel: 718 430 3725 32 Email: [email protected] 33 34 Richard N.
    [Show full text]
  • A Novel Mutation in the MFN2 Gene Associated with Hereditary Sensory
    ISSN: 2378-3648 Hettiaracchchi et al. J Genet Genome Res 2018, 5:039 DOI: 10.23937/2378-3648/1410039 Volume 5 | Issue 1 Journal of Open Access Genetics and Genome Research CASe RePoRT A Novel Mutation in the MFN2 Gene Associated with Hereditary Sensory and Motor Neuropathy with Proximal Predominance (HMSN-P)- A Case Report D Hettiarachchi*, T K Wetthasinghe, N F Neththikumara, BAPS Pathirana and VHW Dissanayake Human Genetics Unit, Faculty of Medicine, University of Colombo, Sri Lanka *Corresponding author: Dr. Dineshani Hettiarachchi, Lecturer, Department of Anatomy, Faculty of Medi- Check for updates cine, University of Colombo, Sri Lanka, Tel: +9477-722-2228 Abstract MarieeTooth disease (CMT) and the hereditary sensory neuropathies there is a significant sensory involvement Background: Mutations in mitofusin 2 gene have been re- ported in Charcot-Marie-Tooth type 2 disease also known as along with distal lower motor neuron weakness [2]. The Hereditary Sensory and Motor Neuropathy. With its cytoge- classical phenotype of HMSN is a length-dependent mo- netic location: 1p36.22. tor weakness and atrophy, primarily affecting the intrin- Case presentation: A 43-year-old female with a family his- sic foot muscles and the peroneal compartment of the tory of neuropathy was experiencing gradual deterioration leg, often leading to foot deformities such as pes cavus, and proximal weakness of the bilateral lower limb for the pes planus, and clawing of the toes [3]. past 3 years. Her MRI scan (Brain and whole Spinal) was normal and Electromyography (EMG) report was sugges- Mutations in the mitofusin 2 (MFN2) gene, which tive of motor & sensory demyelinating polyneuropathy with encodes a mitochondrial GTPase mitofusin protein, features of segmental involvement.
    [Show full text]
  • Functional Characterization of Novel Rhot1 Variants, Which Are Associated with Parkinson’S Disease
    FUNCTIONAL CHARACTERIZATION OF NOVEL RHOT1 VARIANTS, WHICH ARE ASSOCIATED WITH PARKINSON’S DISEASE DISSERTATION zur Erlangung des Grades eines DOKTORS DER NATURWISSENSCHAFTEN DER MATHEMATISCH-NATURWISSENSCHAFTLICHEN FAKULTÄT und DER MEDIZINISCHEN FAKULTÄT DER EBERHARD-KARLS-UNIVERSITÄT TÜBINGEN vorgelegt von DAJANA GROßMANN aus Wismar, Deutschland Mai 2016 II PhD-FSTC-2016-15 The Faculty of Sciences, Technology and Communication The Faculty of Science and Medicine and The Graduate Training Centre of Neuroscience DISSERTATION Defense held on 13/05/2016 in Luxembourg to obtain the degree of DOCTEUR DE L’UNIVERSITÉ DU LUXEMBOURG EN BIOLOGIE AND DOKTOR DER EBERHARD-KARLS-UNIVERISTÄT TÜBINGEN IN NATURWISSENSCHAFTEN by Dajana GROßMANN Born on 14 August 1985 in Wismar (Germany) FUNCTIONAL CHARACTERIZATION OF NOVEL RHOT1 VARIANTS, WHICH ARE ASSOCIATED WITH PARKINSON’S DISEASE. III IV Date of oral exam: 13th of May 2016 President of the University of Tübingen: Prof. Dr. Bernd Engler …………………………………… Chairmen of the Doctorate Board of the University of Tübingen: Prof. Dr. Bernd Wissinger …………………………………… Dekan der Math.-Nat. Fakultät: Prof. Dr. W. Rosenstiel …………………………………… Dekan der Medizinischen Fakultät: Prof. Dr. I. B. Autenrieth .................................................. President of the University of Luxembourg: Prof. Dr. Rainer Klump …………………………………… Supervisor from Luxembourg: Prof. Dr. Rejko Krüger …………………………………… Supervisor from Tübingen: Prof. Dr. Olaf Rieß …………………………………… Dissertation Defence Committee: Committee members: Dr. Alexander
    [Show full text]
  • VPS35, the Retromer Complex and Parkinson's Disease
    Journal of Parkinson’s Disease 7 (2017) 219–233 219 DOI 10.3233/JPD-161020 IOS Press Review VPS35, the Retromer Complex and Parkinson’s Disease Erin T. Williamsa,b, Xi Chena and Darren J. Moorea,∗ aCenter for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, USA bVan Andel Institute Graduate School, Van Andel Research Institute, Grand Rapids, MI, USA Accepted 13 January 2017 Abstract. Mutations in the vacuolar protein sorting 35 ortholog (VPS35) gene encoding a core component of the retromer complex, have recently emerged as a new cause of late-onset, autosomal dominant familial Parkinson’s disease (PD). A single missense mutation, AspD620Asn (D620N), has so far been unambiguously identified to cause PD in multiple individuals and families worldwide. The exact molecular mechanism(s) by which VPS35 mutations induce progressive neurodegeneration in PD are not yet known. Understanding these mechanisms, as well as the perturbed cellular pathways downstream of mutant VPS35, is important for the development of appropriate therapeutic strategies. In this review, we focus on the current knowledge surrounding VPS35 and its role in PD. We provide a critical discussion of the emerging data regarding the mechanisms underlying mutant VPS35-mediated neurodegeneration gleaned from genetic cell and animal models and highlight recent advances that may provide insight into the interplay between VPS35 and several other PD-linked gene products (i.e. ␣-synuclein, LRRK2 and parkin) in PD. Present data support a role for perturbed VPS35 and retromer function in the pathogenesis of PD. Keywords: VPS35, retromer, Parkinson’s disease (PD), endosomal sorting, mitochondria, autophagy, lysosome, ␣-synuclein, LRRK2, parkin INTRODUCTION bradykinesia, resting tremor, rigidity and postural instability, owing to the relatively selective degener- Parkinson’s disease (PD), a common progressive ation of nigrostriatal pathway dopaminergic neurons neurodegenerative movement disorder, belongs to the [1, 2].
    [Show full text]
  • Mitophagy in Antiviral Immunity
    fcell-09-723108 September 1, 2021 Time: 10:49 # 1 REVIEW published: 03 September 2021 doi: 10.3389/fcell.2021.723108 Mitophagy in Antiviral Immunity Hongna Wang1,2,3*, Yongfeng Zheng1,2, Jieru Huang1,2 and Jin Li1,2* 1 Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China, 2 Key Laboratory of Cell Homeostasis and Cancer Research of Guangdong Higher Education Institutes, Guangzhou, China, 3 GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, China Mitochondria are important organelles whose primary function is energy production; in addition, they serve as signaling platforms for apoptosis and antiviral immunity. The central role of mitochondria in oxidative phosphorylation and apoptosis requires their quality to be tightly regulated. Mitophagy is the main cellular process responsible for mitochondrial quality control. It selectively sends damaged or excess mitochondria to the lysosomes for degradation and plays a critical role in maintaining cellular homeostasis. However, increasing evidence shows that viruses utilize mitophagy to promote their survival. Viruses use various strategies to manipulate mitophagy to Edited by: eliminate critical, mitochondria-localized immune molecules in order to escape host Shou-Long Deng, immune attacks. In this article, we will review the scientific advances in mitophagy in Peking Union Medical College, China viral infections and summarize how the host immune system responds to viral infection Reviewed by: and how viruses manipulate host mitophagy
    [Show full text]